Obesity-Related Secondary FSGS — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Obesity-related secondary FSGS (adaptive FSGS from glomerular hyperfiltration)
Glomerulomegaly with perihilar (not tip or cellular) segmental sclerosis, no immune deposits, in a morbidly obese patient is classic for obesity-related secondary FSGS. The mechanism is glomerular hyperfiltration from increased metabolic demand. Unlike primary FSGS, foot process effacement on EM is typically segmental (not diffuse). Treatment is weight loss (which can dramatically reduce proteinuria), RASi, and SGLT2i. Immunosuppression is NOT indicated for secondary FSGS – steroids would be harmful.
Reference: KDIGO 2021 – GN Guideline; Kambham et al 2001 – Obesity FSGS